GLP-1 meds like Ozempic, Wegovy may lower cancer risk

A study suggests GLP-1 medications like Ozempic and Wegovy may lower the risk of certain cancers. Overweight individuals face a higher risk of 13 types of cancer, with 40% of new diagnoses linked to excess weight. GLP-1 treatment reduced the risk of 10 obesity-associated cancers, including gallbladder, pancreatic, and liver cancer. The study analyzed data from 1.7 million people with type 2 diabetes. Further research is needed on the relationship between weight loss and cancer risk reduction.